Serum Levels of Transforming Growth Factor Beta1 (TGF β1) in Patients with Alopecia Areata.
نویسندگان
چکیده
منابع مشابه
Maternal Serum Levels of Transforming Growth Factor ß1 (TGF-ß1) in Normal and Preeclamptic Pregnancies
Background: Successful pregnancy in allopregnant women depends upon the control of graft rejection mechanisms. It has been suggested that some immunosuppressive cytokines contribute to successful pregnancy and transplantation. Transforming growth factor beta (TGF- β) exhibits potent immunoregulatory and anti-inflammatory properties which might prolong graft survival. Recent studies suggest a ...
متن کاملSerum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
BACKGROUND Transforming growth factor-β1 (TGF-β1) exerts broad anti-inflammatory and immunosuppressive effects and plays a key role in self-tolerance. Complete knockout of TGF-β1 in mice results in autoimmunity and multi-organ inflammatory syndrome. The aim of the present study was to determine TGF-β1 serum levels in healthy individuals and in patients with typical systemic or organ-specific au...
متن کاملSerum levels of transforming growth factor beta1 in patients with breast cancer.
HYPOTHESIS Transforming growth factor beta1 (TGF-beta1) may be related to breast cancer progression. DESIGN Prospective study. SETTING University hospital. PATIENTS Sixty consecutive patients with invasive breast cancer undergoing surgery were prospectively included and evaluated. The control group consisted of 14 patients with benign breast tumors (7 with fibrocystic disease and 7 with f...
متن کاملHigh Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib.
BACKGROUND The TGF-β signaling pathway is crucial in the progression and metastasis of malignancies. We investigated whether the serum TGF-β1 level was related to the outcomes of patients treated with sorafenib for advanced hepatocellular carcinoma (HCC). EXPERIMENTAL DESIGN We selected patients who had received sorafenib-containing regimens as first-line therapy for advanced HCC between 2007...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Benha Medical Journal
سال: 2020
ISSN: 2357-0016
DOI: 10.21608/bmfj.2020.103934